Daniel P. van Plew - 09 Dec 2025 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Reporting relationship: EVP & General Mgr, Industrial
Issuer ticker: REGN
Reported as of: 09 Dec 2025
Net transaction value: -$1,790,254
SEC form: 4
Accepted by SEC: 11 Dec 2025, 16:34:24 UTC
Prior SEC filing: 09 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Daniel P. Van Plew

Key filing fact

Daniel P. van Plew filed Form 4 for REGENERON PHARMACEUTICALS, INC. (REGN) on 11 Dec 2025.

Key facts

This page summarizes Daniel P. van Plew's Form 4 filing for REGENERON PHARMACEUTICALS, INC. (REGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Dec 2025, 16:34.

Change

Previous filing in this sequence was filed on 09 Dec 2025.
Current net transaction value: -$1,790,254.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001411984 Primary reporting owner

Van Plew Daniel P

Relationship: EVP & General Mgr, Industrial
Address: 777 OLD SAW MILL RIVER ROAD, TARRYTOWN
Signature: /s/ Daniel P. Van Plew
Signature date: 11 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

REGN transaction

Common Stock

Tax liability

Transaction value: $1,790,254
Shares: -2,552
Change %: -11%
Price: $701.51
Shares after: 21,673
Date: 09 Dec 2025
Ownership: Direct

REGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 12,376
Date: 09 Dec 2025
Ownership: By 2025 GRAT

REGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,129
Date: 09 Dec 2025
Ownership: By 401(k) Plan

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .